CoaguSafe - Anticoagulant
For medical professionals, including clinicians and students, involved in anticoagulation management and perioperative care.
Overview · Full Intel report in progress
CoaguSafe - Anticoagulant is an established medical app that is a paid app. With a 4.6/5 rating from 15 reviews, it shows polarized user reception.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Provides access to clinical protocols from organizations including the ESA, DGAI, and various Swiss university hospitals.
Includes information on oral anticoagulants, heparin, factor Xa inhibitors, thrombin inhibitors, and ADP antagonists.
Allows users to organize medications by brand or generic name to support bridging and monitoring workflows.
How much does it cost?
Who Built It?
Girard Development
Providing specialized medical reference tools to assist healthcare professionals in clinical decision-making. These apps offer guidance on medication management and emergency protocols for perioperative care.
Portfolio
3
Apps
What other apps does Girard Development make?
Explore the full Girard Development report
Portfolio breakdown, audience, momentum, and every app published by Girard Development.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for CoaguSafe - Anticoagulant?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
20 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for CoaguSafe - Anticoagulant
Key Takeaways
While the app offers a specialized database for perioperative anticoagulation management, users have reported potential UI display issues and difficulties contacting the developer.
Where Is It Heading?
Trend analysis
Available very soon